Psychiatric disorder vulnerability control agent

摘要

Focusing on the mechanism of brain onset vulnerability, we provide a therapeutic agent for mental illness that compensates for the shortcomings of existing antipsychotic drugs and carries a new mechanism of action. Specifically, for mental disorders whose symptoms show a wavy appearance pattern, by controlling progressive brain dysfunction corresponding to the onset vulnerability, the stress response during remission is sustained and relapses. A new therapeutic agent for psychiatric disorders consisting of a novel mechanism that suppresses the disease, and this therapeutic agent has utility in the treatment of schizophrenia (schizophrenia, schizophrenia), stimulant psychosis, manic depression, etc. The present invention has been completed. That is, the present invention provides a therapeutic agent for mental illness in which a disease symptom having a wavy appearance pattern is mainly composed of a compound having a function of controlling progressive brain dysfunction corresponding to onset vulnerability.